No Data
Rhythm Pharmaceuticals, Inc. (RYTM): Short Seller Sentiment Is Bearish
Rhythm Pharmaceuticals Director Jennifer Good Sells Over $1.6m in Stock
Strength Seen in Rhythm Pharmaceuticals (RYTM): Can Its 7.4% Jump Turn Into More Strength?
H.C. Wainwright Initiates Rhythm Pharmaceuticals(RYTM.US) With Buy Rating, Announces Target Price $64
H.C. Wainwright analyst Ram Selvaraju initiates coverage on $Rhythm Pharmaceuticals(RYTM.US)$ with a buy rating, and sets the target price at $64.According to TipRanks data, the analyst has a
Rhythm Pharma Draws Bullish View at JMP on Opportunity in Rare Genetic Obesities
Rhythm Pharmaceuticals Price Target Announced at $64.00/Share by JMP Securities